Ovid Therapeutics Inc. · NASDAQ:OVID
Madison Avenue Partners, LP's stake in Ovid Therapeutics Inc. fell to 4.00% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Madison Avenue Partners, LP's stake in Ovid Therapeutics Inc. fell to 4.00%, 2,852,352 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.00%
- Shares
- 2,852,352
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Madison Avenue Partners, LP | 4.00% | 2,852,352 |
| Madison Avenue International LP | 4.00% | 2,852,352 |
| EMAI Management, LLC | 4.00% | 2,852,352 |
| Madison Avenue GP, LLC | 4.00% | 2,852,352 |
| Caraway Jackson Investments LLC | 4.00% | 2,852,352 |
| Eli Samaha | 4.00% | 2,852,352 |
Source
Related
- Ovid Therapeutics Inc.
- Madison Avenue Partners, LP
- Ovid Therapeutics Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026